All products
By area
By ATC classifier
! Pharmacovigilance

GLUTAZONE tablets

The active substance:

PIOGLITAZONE

Indications for use:

Treatment of II type diabetes mellitus:

as monotherapy

  • in patients (especially in obese patients) with contraindications and intolerance to metformin in case of inadequate control or glucose level with diet and exercises;

as double combined therapy with

  • metformin in patients (especially in obese patients) with insufficient glycemic control despite using maximum tolerated dose of metformin;
  • sulfonylurea derivatives only in patients with contraindications and intolerance to metformin in case of insufficient glycemic control despite using maximum tolerated dose of sulfonylurea derivatives;

as triple combined therapy with

  • metformin and sulfonylurea derivatives in patients (especially in obese patients) with insufficient glycemic control despite using double combined therapy.

Glutazone® is also indicated in combination with insulin in patients with II type diabetes mellitus with insufficient glycemic control despite using insulin, who have contraindications or intolerance to metformin.

1 tablet contains pioglitazone hydrochloride equivalent to pioglitazone 15 mg or 30 mg, or 45 mg; Antidiabetic drugs. Hypoglycemic drugs, excluding insulins. Thiazolidinediones.

For detailed information, please see instruction for medical use.
Twitter
Facebook
Фармаконадзор